| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel & COO
1 company
Robert Ticktin is General Counsel & COO at PMVP. Robert Ticktin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $136K at current prices.
The PMVP filings lean toward selling, a net 23,151 shares.
Robert Ticktin has 2 Form 4 filings on record from July 2025 to March 2026, all as General Counsel & COO at PMV Pharmaceuticals (PMVP), 2025–2026.
The 2 reported transactions were 1 option or other derivative award and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $25K.
The only open-market sale was 23,151 shares of PMVP at an average $1.06 on July 1, 2025, about $25K. Twelve months later PMVP was up 18%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | PMVP Pmv Pharmaceuticals, Inc. | General Counsel & COO | Sell | 23,151 | $1.06 | $24,651.18 | -19.0% | +38.1% | +18.1% |